A Cost-Effectiveness Analysis between Amlodipine and Angiotensin II Receptor Blockers in Stroke and Myocardial Infarction Prevention among Hypertension Patients in China

Amlodipine is a cost-saving therapy compared with ARBs in preventing stroke and MI for Chinese HTN patients.